BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12128238)

  • 1. Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder.
    Candido CL; Romney DM
    J Affect Disord; 2002 Aug; 70(3):261-71. PubMed ID: 12128238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between and among schizophrenics and other pathologies using a Spanish version of the Whitaker Index of Schizophrenic Thinking.
    Godoy JF; Fernandez M; Muela JA; Roldan G; Catena A; Puente AE
    J Clin Psychol; 1994 Mar; 50(2):158-61. PubMed ID: 8014238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paranoid schizophrenia: an unorthodox view.
    Zigler E; Glick M
    Am J Orthopsychiatry; 1984 Jan; 54(1):43-70. PubMed ID: 6703023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of depression for different types of schizophrenia.
    Strian F; Heger R; Klicpera C
    Psychiatr Clin (Basel); 1981; 14(4):205-14. PubMed ID: 7346895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paranoid and nonparanoid schizophrenic processing of facially displayed affect.
    Kline JS; Smith JE; Ellis HC
    J Psychiatr Res; 1992 Jul; 26(3):169-82. PubMed ID: 1432844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self psychology conceptualization of postpsychotic depression and recovery among paranoid schizophrenic patients.
    Potik D
    Bull Menninger Clin; 2014; 78(1):70-86. PubMed ID: 24552430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.
    Zalewski C; Johnson-Selfridge MT; Ohriner S; Zarrella K; Seltzer JC
    Schizophr Bull; 1998; 24(1):127-45. PubMed ID: 9502551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid and rigid boundaries of paranoid and nonparanoid schizophrenics on a role-playing task.
    Johnson D; Quinlan D
    J Pers Assess; 1980 Oct; 44(5):523-31. PubMed ID: 7431201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylthiocarbamide (PTC) tasting in paranoid and nonparanoid schizophrenic patients.
    Schlosberg A; Baruch I
    Percept Mot Skills; 1992 Apr; 74(2):383-6. PubMed ID: 1594398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal recall in schizophrenia: differential effect of retroactive interference in nonparanoid patients.
    Sengel RA; Lovallo WR; Pishkin V
    Compr Psychiatry; 1985; 26(2):164-74. PubMed ID: 3987245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-demographic and clinical profiles of paranoid and nonparanoid schizophrenia: a prospective, multicenter study in China.
    Xiang YT; Wang CY; Chiu HF; Weng YZ; Bo QJ; Chan SS; Lee EH; Ungvari GS
    Perspect Psychiatr Care; 2011 Jul; 47(3):126-30. PubMed ID: 21707627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach.
    Cassano GB; Rucci P; Frank E; Fagiolini A; Dell'Osso L; Shear MK; Kupfer DJ
    Am J Psychiatry; 2004 Jul; 161(7):1264-9. PubMed ID: 15229060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paranoid and nonparanoid schizophrenia: drive dominated thinking and thought pathology at two phases of disorder.
    Lazar BS; Harrow M
    J Clin Psychol; 1985 Mar; 41(2):145-51. PubMed ID: 3980736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction.
    Auslander LA; Perry W; Jeste DV
    Schizophr Res; 2002 Jan; 53(3):199-207. PubMed ID: 11738533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between paranoid and nonparanoid schizophrenic patients on the somatosensory P300 event-related potential.
    Louzã MR; Maurer K
    Neuropsychobiology; 1989; 21(2):59-66. PubMed ID: 2615924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia.
    Pinkham AE; Liu P; Lu H; Kriegsman M; Simpson C; Tamminga C
    Am J Psychiatry; 2015 Aug; 172(8):784-92. PubMed ID: 25815418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paranoid schizophrenia in adolescence.
    Apter A; Spivak B; Weizman A; Tyano S; Orvaschel H
    J Clin Psychiatry; 1991 Sep; 52(9):365-8. PubMed ID: 1894588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the mental representations of paranoid schizophrenics be differentiated from those of normals?
    Johnson DR; Quinlan DM
    J Pers Assess; 1993 Jun; 60(3):588-601. PubMed ID: 8336271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.